Herve Bonnefoi

Herve Bonnefoi

UNVERIFIED PROFILE

Are you Herve Bonnefoi?   Register this Author

Register author
Herve Bonnefoi

Herve Bonnefoi

Publications by authors named "Herve Bonnefoi"

Are you Herve Bonnefoi?   Register this Author

59Publications

1661Reads

22Profile Views

Category "viewpoints and debates" Is trastuzumab as a single agent obsolete in early breast cancer? Yes.

Breast 2019 Feb 20;43:146-148. Epub 2018 Oct 20.

Department of Medical Oncology, Institut Bergonié Unicancer, Univ. Bordeaux, INSERM U1218, INSERM CIC1401, Bordeaux, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.breast.2018.10.008DOI Listing
February 2019

Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer.

N Engl J Med 2018 Jul 4;379(2):122-137. Epub 2018 Jun 4.

From the Peter MacCallum Cancer Centre, St. Vincent's Hospital, University of Melbourne, Melbourne, VIC, and Breast Cancer Trials Australia and New Zealand, University of Newcastle, Newcastle, NSW (P.A.F.), and the University of Sydney, Sydney (A.S.C.) - all in Australia; the Institute of Oncology of Southern Switzerland, Ospedale San Giovanni, Bellinzona (O.P.), Breast Cancer St. Gallen, St. Gallen (T.R.), and the International Breast Cancer Study Group Coordinating Center (R.M., M.R.-P., B.R., A.S.C.), University Hospital Inselspital (M.R.-P.), Bern - all in Switzerland; the University of Chicago Medical Center, Chicago (G.F.F.); the University of Calgary, Calgary, AB, Canada (B.A.W.); the Division of Medical Senology, European Institute of Oncology (M.C.), and the European Institute of Oncology and International Breast Cancer Study Group (A.G.), Milan, Ospedale Papa Giovanni XXIII, Bergamo (C.T.), Azienda Socio Sanitaria Territoriale Sette Laghi-Ospedale di Circolo and Fondazione Macchi, Varese (G.P.), Medical Oncology and Cancer Prevention, IRCCS, National Cancer Institute, Aviano (F.P., S.S.), the Department of Medicine, School of Medical Oncology, University of Udine, Udine (F.P.), Salvatore Maugeri Foundation, Pavia (L.P.), and the Hospital of Prato-Azienda Unità Sanitaria Locale Toscana Centro, Prato (A.D.L.) - all in Italy; the National Institute of Oncology, Budapest, Hungary (I.L.); Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru (H.L.G.); University Hospital 12 de Octubre, Madrid (E.C.), Vall d'Hebron Institute of Oncology and Vall d'Hebron University Hospital, Barcelona (M.B.), and Instituto Valenciano de Oncologia, Valencia (M.A.C.) - all in Spain; the Susan F. Smith Center for Women's Cancers (H.J.B., E.P.W.) and the International Breast Cancer Study Group Statistical Center, Department of Biostatistics and Computational Biology (R.D.G., M.M.R.), Dana-Farber Cancer Institute, Harvard Medical School, the Harvard T.H. Chan School of Public Health, and Frontier Science and Technology Research Foundation (R.D.G.) - all in Boston; Institut Bergonié Comprehensive Cancer Center, Université de Bordeaux, Bordeaux, France (H.R.B., M.D.); the Angeles Clinic and Research Institute, Santa Monica, CA (S.M.); Massey Cancer Center, Virginia Commonwealth University School of Medicine, Richmond (C.E.G.); Mayo Clinic, Rochester, MN (M.P.G., J.N.I.); Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore (V.S.); Fred Hutchinson Cancer Research Center, University of Washington, Seattle (N.E.D.); Weston Park Hospital, Sheffield, United Kingdom (R.C.); and the Department of Obstetrics and Gynecology, University Medical Center, Regensburg, Germany (S.B.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1803164DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6193457PMC
July 2018

Do patients whose tumor achieved a pathological response relapse at specific sites? A substudy of the EORTC 10994/BIG-1-00 trial.

Breast Cancer Res Treat 2018 Jun 12;169(3):497-505. Epub 2018 Feb 12.

Department of Medical Oncology, Institut Bergonié Unicancer, Université de Bordeaux, INSERM U1218, INSERM CIC1401, 229 Cours de l'Argonne, 33000, Bordeaux, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-018-4698-xDOI Listing
June 2018

Factors predictive of locoregional recurrence following neoadjuvant chemotherapy in patients with large operable or locally advanced breast cancer: An analysis of the EORTC 10994/BIG 1-00 study.

Eur J Cancer 2017 07 18;79:226-234. Epub 2017 May 18.

Department of Medical Oncology, Institut Bergonié Unicancer, Univ. Bordeaux, INSERM U1218, INSERM CIC1401 Bordeaux, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2017.04.012DOI Listing
July 2017

MICADo - Looking for Mutations in Targeted PacBio Cancer Data: An Alignment-Free Method.

Front Genet 2016 8;7:214. Epub 2016 Dec 8.

Centre de BioInformatique de Bordeaux, University of BordeauxBordeaux, France; Laboratoire Bordelais de Recherche en Informatique, Centre National de la Recherche Scientifique, University of BordeauxBordeaux, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fgene.2016.00214DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5143680PMC
December 2016

The mammary ducts create a favourable microenvironment for xenografting of luminal and molecular apocrine breast tumours.

J Pathol 2016 11 29;240(3):256-261. Epub 2016 Sep 29.

INSERM U1218, Bergonie Cancer Institute, University of Bordeaux, 33076, Bordeaux, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/path.4772DOI Listing
November 2016

Precision medicine for metastatic breast cancer--limitations and solutions.

Nat Rev Clin Oncol 2015 Dec 21;12(12):693-704. Epub 2015 Jul 21.

Department of Medical Oncology, Gustave Roussy and Université Paris Sud, 94800 Villejuif, France.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/nrclinonc.2015.123
Publisher Site
http://dx.doi.org/10.1038/nrclinonc.2015.123DOI Listing
December 2015

Bevacizumab: the phoenix of breast oncology?

Lancet Oncol 2015 Jun 11;16(6):600-1. Epub 2015 May 11.

Department of Medical Oncology, Institut Bergonie, Bordeaux, France.

View Article

Download full-text PDF

Source
http://www.thelancet.com/pdfs/journals/lanonc/PIIS1470-2045(
Web Search
http://linkinghub.elsevier.com/retrieve/pii/S147020451570201
Publisher Site
http://dx.doi.org/10.1016/S1470-2045(15)70201-9DOI Listing
June 2015

[Oncofertility and breast cancer: Where have we come from, where are we going?].

Bull Cancer 2015 Jun 16;102(6):489-96. Epub 2015 May 16.

Institut de lutte contre le cancer, institut Bergonié, service de chirurgie, Bordeaux, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bulcan.2015.04.004DOI Listing
June 2015

Validation of a yeast functional assay for p53 mutations using clonal sequencing.

J Pathol 2013 Dec;231(4):441-8

INSERM U916, Institut Bergonié Comprehensive Cancer Centre, Univ. Bordeaux, F-33000, Bordeaux, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/path.4243DOI Listing
December 2013

Imaging features of sporadic breast cancer in women under 40 years old: 97 cases.

Eur Radiol 2013 Dec 6;23(12):3237-45. Epub 2013 Aug 6.

Department of Radiology, Institut Bergonié, Comprehensive Cancer Centre, F-33000, Bordeaux, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00330-013-2966-zDOI Listing
December 2013

Anthracyclines, HER2, and TOP2A: the verdict.

Lancet Oncol 2011 Nov 12;12(12):1084-5. Epub 2011 Sep 12.

Institut Bergonié, Université Segalen, INSERM U916, Bordeaux, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(11)70241-8DOI Listing
November 2011

ASCO 2009: What's New in Breast Cancer Therapy?

Breast Care (Basel) 2009 14;4(4):268-271. Epub 2009 Aug 14.

'Sandro Pitigliani' Medical Oncology Unit, Department of Oncology, Hospital of Prato, Tuscany Cancer Institute, Prato, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000230677DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2941658PMC
August 2009

Predictive signatures for chemotherapy sensitivity in breast cancer: are they ready for use in the clinic?

Eur J Cancer 2009 Jul 26;45(10):1733-43. Epub 2009 May 26.

Bergonié Cancer Institute and University of Bordeaux, Bordeaux Cedex, France.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S095980490900335
Publisher Site
http://dx.doi.org/10.1016/j.ejca.2009.04.036DOI Listing
July 2009

A stroma-related gene signature predicts resistance to neoadjuvant chemotherapy in breast cancer.

Nat Med 2009 Jan 4;15(1):68-74. Epub 2009 Jan 4.

Swiss National Centre of Competence in Research Molecular Oncology, Swiss Institute for Experimental Cancer Research, Ecole Polytechnique Fédérale de Lausanne, School of Life Sciences, Epalinges s/Lausanne, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nm.1908DOI Listing
January 2009

[New predictive factors for chemosensitivity of breast cancers].

Bull Cancer 2008 Oct;95(10):943-50

Institut Bergonié et université de Bordeaux-II, Bordeaux.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1684/bdc.2008.0729DOI Listing
October 2008

An oestrogen-dependent model of breast cancer created by transformation of normal human mammary epithelial cells.

Breast Cancer Res 2007 ;9(3):R38

NCCR Molecular Oncology, Swiss Institute for Experimental Cancer Research (ISREC), Chemin des Boveresses 155, CH-1066 Epalinges, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/bcr1734DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1929103PMC
September 2007

Clinical trials update of the European Organization for Research and Treatment of Cancer Breast Cancer Group.

Breast Cancer Res 2004 16;6(4):165-9. Epub 2004 Jun 16.

Department of Surgery, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/bcr906DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC468675PMC
November 2004

[First-line chemotherapy of breast cancer: new standard at specialized units].

Rev Med Suisse Romande 2003 May;123(5):309-12

Département de Gynécologie-Obstétrique, Service de Gynécologie, Hôpitaux Universitaires de Genève.

View Article

Download full-text PDF

Source
May 2003

Vaginal stenosis with hematocolpometra, complicating chronic graft versus host disease.

Eur J Obstet Gynecol Reprod Biol 2002 Jul;103(2):185-7

Department of Gynaecology and Obstetrics, University Hospital of Geneva, 1211 14, Geneva, Switzerland.

View Article

Download full-text PDF

Source
July 2002